secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2026-10-09T20:15:22+00:00
Accession:  0001683168-26-007749
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Aethlon Medical boosts authorized common shares 10x to 200M, effective Oct 7
----------------------------------------------------------------------------

- Authorized common stock, $0.001 par value, rises from 20,000,000 to 200,000,000 shares, amending Article V of the Articles of Incorporation.
- Stockholders approved the amendment at the 2026 Annual Meeting held October 1, 2026; Certificate of Amendment filed with the Nevada Secretary of State and effective October 7, 2026.
- Filing discloses no issuance, pricing, or intended use of proceeds for the newly authorized shares, and no corresponding financing was announced.
- Certificate of Amendment attached as Exhibit 3.1; filing signed October 9, 2026 by CEO and CFO James B. Frakes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316826007749/0001683168-26-007749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316826007749/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-007749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer